US2008038313A1PendingUtilityA1
Systems, methods, and compositions for mixing and applying lyophilized biomaterials
Est. expiryNov 6, 2018(expired)· nominal 20-yr term from priority
A61B 2017/0065A61P 17/02A61B 17/0057A61B 2017/00637A61B 2017/00495A61B 2017/00004A61B 17/00491
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of treating tissue lyophilizes a biocompatible polymer having a functionality equal to or greater than three. The method provides a protein solution. The method mixes the protein solution with the lyophilized polymer to reconstitute the polymer and form a mixture, wherein, upon mixing, the protein solution and the polymer cross-link to form a material composition. The method applies the material composition to a tissue region. The biocompatible polymer can comprise, e.g., poly(ethylene glycol) PEG. The protein solution can comprise, e.g., albumin.
Claims
exact text as granted — not AI-modified1 . A method comprising
providing a first container holding a biocompatible polymer in lyophilized form, the biocompatible polymer having a functionality equal to or greater than three, providing a second container holding a protein solution introducing the protein solution into the first container for mixing with the polymer in lyophilized form to reconstitute the polymer and form a mixture, wherein, upon mixing, the protein solution and the polymer cross-link.
2 . A method according to claim 1 wherein the biocompatible polymer comprises poly(ethylene glycol) PEG.
3 . A method according to claim 1 wherein the protein solution comprises albumin.
4 . A system comprising
a first container holding a biocompatible polymer in lyophilized form, the biocompatible polymer having a functionality equal to or greater than three, a second container holding a protein solution an applicator to introduce the protein solution into the first container for mixing with the polymer in lyophilized form to reconstitute the polymer and form a mixture, wherein, upon mixing, the protein solution and the polymer cross-link.
5 . A system according to claim 4 wherein the biocompatible polymer comprises poly(ethylene glycol) PEG.
6 . A system according to claim 4 wherein the protein solution comprises albumin.
7 . A method of treating tissue comprising
lyophilizing a biocompatible polymer having a functionality equal to or greater than three; providing a protein solution, mixing the protein solution with the lyophilized polymer to reconstitute the polymer and form a mixture, wherein, upon mixing, the protein solution and the polymer cross-link to form a material composition, and applying the material composition to a tissue region.
8 . A method according to claim 7 wherein the biocompatible polymer comprises poly(ethylene glycol) PEG.
9 . A method according to claim 7 wherein the protein solution comprises albumin.
10 . A method comprising
lyophilizing a biocompatible polymer having a functionality equal to or greater than three, providing a protein solution, and mixing the protein solution with the lyophilized polymer to reconstitute the polymer and form a mixture, wherein, upon mixing, the protein solution and the polymer cross-link to form a material composition.
11 . A method according to claim 10 wherein the biocompatible polymer comprises poly(ethylene glycol) PEG.
12 . A method according to claim 10 wherein the protein solution comprises albumin.
13 . A method of treating tissue comprising lyophilizing a biocompatible polymer having a functionality equal to or greater than three,
providing a protein solution, providing a catheter, mixing the protein solution with the lyophilized polymer to reconstitute the polymer and form a mixture, wherein, upon mixing, the protein solution and the polymer cross-link to form a material composition, and applying the material composition through the catheter to a tissue region.
14 . A method according to claim 13 wherein the biocompatible polymer comprises poly(ethylene glycol) PEG.
15 . A method according to claim 13 wherein the protein solution comprises albumin.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.